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Available online 4 June 2016This report discusses a case of nonconvulsive status epilepticus, caused by cerebral amyloid angiopathy-related
inﬂammation. Brain biopsy demonstrated cerebral amyloid angiopathy, with clinical and radiographic features
indicative of a ﬂuctuating inﬂammatory process. Immunomodulatory treatment with pulse steroids resulted in
rapid and dramatic clinical and radiographic improvement. Cerebral amyloid angiopathy-related inﬂammation
should be considered in the differential diagnosis of new-onset seizures after the age of 40, when associated
withﬂuctuatingmultifocal T2 hyperintensities and petechial hemorrhages on gradient echo (GRE) or susceptibil-
ity-weighted (SWI) MRI sequences.
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Pathology1. Case report
We present a case of status epilepticus due to cerebral amyloid
angiopathy-related inﬂammation, successfully treated with
immunomodulation. A 52-year-old man with a history of hypertension
and alcohol abuse, presented in January of 2015with new-onset seizures.
The patient's family ﬁrst noted new-onset irritability, paranoia, and con-
fusion thatwere thought to be atypical for him. Twodays later, the patient
noted a 45-minute episode of elementary visual hallucinations consisting
of bright colors and stars in his right visual ﬁeld with an associated ex-
pressive aphasia. He reported that he could understandquestions and for-
mulate responses in his head but not actually speak.
Hewas brought to an outside hospital where he had awitnessed sei-
zure during which he had deviation of his head to the left, evolving to a
generalized tonic-convulsion seizure lasting 40 seconds,with associated
tongue biting and postictal confusion but no incontinence. His exam
was notable only for a right inferior quadrant visual ﬁeld defect, which
was homonymous but more profound in the right eye. A lumbar punc-
ture was performed, and cerebrospinal ﬂuid was acellular with normal
protein and glucose, with no oligoclonal bands, andwith negative cytol-
ogy andﬂow cytometry. Routine electroencephalograms (EEGs) showed
spike–wave discharges with several electrographic seizures in the left
occipital region. Magnetic resonance imaging (MRI) revealed left occipi-
tal white matter and cortical T2 hyperintensity with mild focal mass ef-
fect, without enhancement but with petechial hemorrhages on1 617 730 2885.
. This is an open access article undergradient echo (GRE) imaging and with a second smaller focus of T2
hyperintensity in the left anterior insula (Fig. 1). Magnetic resonance an-
giography of the head and neck was unremarkable. He was loaded with
levetiracetam and was discharged from the hospital.
Upon initial formulation, the patient's history, exam, and studies
were thought to be most consistent with a multifocal glioma, less likely
an infectious or inﬂammatory process, and even less likely an old stroke.
His levetiracetam dose was increased because of a recurrent episode of
visual symptoms and aphasia, and he was scheduled for a biopsy of the
left occipital lesion. However, a repeatMRI performed in March 2015 in
preparation for the biopsy showed signiﬁcant improvement of the left
occipital and left anterior insular lesions (Fig. 2B). These shifting
lesions were thought to be more consistent with a demyelinating pro-
cess such as acute disseminated encephalomyelitis (ADEM).
The brain biopsywas aborted, and the patient was instead admitted for
an expedited inﬂammatory workup. A repeat lumbar puncture was again
unrevealing (including negative oligoclonal bands, cytology, ﬂow cytome-
try, and IgH gene rearrangement). A computed tomography (CT) scan of
the chest, abdomen, and pelvis revealedmultiple 1- to 2-cmhepatic lesions
with peripheral nodular enhancements, which were then conﬁrmed as
hepatic hemangiomas on abdominal MRI. Magnetic resonance imaging of
the cervical and thoracic spine showed onlymild degenerative disc disease,
and CT angiogram of the head and neck was unremarkable.
The patient was again discharged home, but follow-up MRI in June
2015 showed worsening of the left occipital T2 hyperintensity
(Fig. 2C) and new left frontal T2 hyperintensities, as well as new
enhancement of the lesion in the right anterior temporal lobe (not
shown). Biopsy of the left occipital lesion was performed. The biopsythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Axial T2MRI FLAIR sequenceswithmultifocal hyperintensities in the right temporal
lobe (A), left anterior insula (B), and left occipital lobe (B, C). Blooming artifact over the left
occipital region showing micro hemorrhages on the gradient echo sequences (D).
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amyloid deposition in vessel walls (Fig. 3). These ﬁndings were thought
to be consistent with cerebral amyloid angiopathy.
He was then brought to the emergency department for a sudden
clinical deterioration with global aphasia and confusion. He was
unable to name objects, repeat phrases, or follow commands; made
frequent paraphasic errors; and was noted to have decreased blink
to threat on the right. An EEG was obtained, revealing continuous
lateralized periodic discharges with overlying fast activity over the
left posterior quadrant (Fig. 4A), evolving into 3–4 electrographic
seizures per hour (Fig. 4B), consisting of 9-Hz rhythmic sharp
waves, without clinical return to baseline between seizures. He was
therefore determined to be in nonconvulsive status epilepticus
(NCSE) and was admitted. Over the course of approximately 24 h,
he was started on lacosamide, phenytoin, and valproic acid in
addition to levetiracetam, and NCSE was aborted. Notably, Mr. G's
clinical status improved only slightly with the arrest of seizures,
and he continued to demonstrate signiﬁcant global aphasia and
confusion.Fig. 2. Relapsing appearance of the left posterior quadrant lesion at 1 month, 3 mPositron emission tomography (PET) scan of the brain and whole
body revealed increased ﬂuorodeoxyglucose (FDG) uptake in the left
occipital and left temporal regions, consistent with the known lesions
on MRI. These areas of increased FDG uptake were thought to be most
likely due to an inﬂammatory process and less likely due to recent
seizure activity. At this point, the diagnosis of cerebral amyloid
angiopathy-related inﬂammation was advanced, and he was started
on a 5-day course of methylprednisolone, 1000 mg daily as a diagnostic
and therapeutic maneuver. Clinically, his speech difﬁculties and confu-
sion resolved almost entirely, and he was able to name, repeat, and
follow commands normally. He was able to discontinue phenytoin
and valproic acid without recurrence of seizures (either clinically or
on EEG). Following pulse-dose steroids, he was discharged on a slow
taper of oral prednisone. Repeat imaging in September of 2015 showed
marked improvement of all T2 hyperintense lesions and complete reso-
lution of all enhancement (Fig. 2D).
2. Discussion
Cerebral amyloid angiopathy (CAA) consists of β-amyloid deposi-
tion in small and medium arteries of the brain and leptomeninges [1].
It is found in 23–57% of the asymptomatic elderly population and at in-
creased rates in those with dementia and intracerebral hemorrhage [2].
Cerebral amyloid angiopathy can more rarely cause an inﬂammatory
reaction, known as CAA-related inﬂammation (CAA-I). This has histori-
cally been described as primary angiitis of the central nervous system
associated with CAA, cerebral amyloid angiitis, and cerebral amyloid in-
ﬂammatory vasculopathy [3–5]. Cerebral amyloid angiopathy-related
inﬂammation presents with subacute cognitive decline, headaches,
and seizures rather than the chronic dementia or hemorrhagic strokes
classically associated with cerebral amyloid angiopathy. The mean age
at onset is approximately 68 years, signiﬁcantly younger than for
hemorrhagic CAA. Magnetic resonance imaging ﬁndings in CAA-I in-
clude shiftingmultifocalwhitematter T2 hyperintensities abnormalities
colocalized with petechial hemorrhages on SWI [6]. Cerebrospinal ﬂuid
is typically bland, though protein may be elevated, and more rarely,
pleiocytosis has been observed [3]. The APOE ε4/ε4 genotype is present
at increased rates — 71% of patients in one case series [6]. Histopatho-
logic ﬁndings include amyloid deposition within vessel walls
and perivascular, transmural, or intramural inﬂammation, including
perivascular multinucleated giant cells.
Several published cases and case series describe treatment with im-
munosuppressive therapy, including corticosteroids with or without
additional immunosuppressive therapy such as methotrexate, myco-
phenolate mofetil, or most commonly cyclophosphamide. Thirty-eight
of 53 published cases showed improvement with immunosuppressive
treatment, as did Mr. G [3].
Our patient's case was notable for a typically subacute ﬂuctuating
clinical course andmultifocal ﬂuctuating radiographic ﬁndings, classically
bland CSF, and a biopsy demonstrating amyloid deposition within arteryonths, 6 months, and 9 months of symptom onset (A, B, C, D, respectively).
Fig. 3. Hematoxylin and eosin (H&E) staining showed reactive changes including vacuolization suggestive of edema and astrocytosis/gliosis (A). Glial ﬁbrillary acidic protein (GFAP)
staining highlighted reactive astrocytes (B). H&E staining also demonstrated thickened blood vessels with perivascular hemosiderin deposition (C), and beta-amyloid
immunohistochemistry revealed beta-amyloid deposition in blood vessel walls (D). These ﬁndings were consistent with cerebral amyloid angiopathy.
Fig. 4. Continuous lateralized periodic discharges with overlying fast activity (LPD + F) over the left posterior quadrant (maximal at O1 N P3/T5) (A), evolving into 3–4 electrographic
seizures per hour, consisting of 9-Hz rhythmic sharp activity (B), without clinical return to baseline between seizures.
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uted to the biopsied lesion being an older, “burned out” lesion already un-
dergoing gliosis. Clinically and radiographically, our patient showed the
commonly dramatic response to immunomodulatory treatment.
Cerebral amyloid angiopathy-related inﬂammation is anunusual but
highly treatable cause of new-onset seizures in themiddle-aged and el-
derly population and should be considered in the differential diagnosisof new-onset seizures after the age of 40, associated with ﬂuctuating
multifocal T2 hyperintensities and petechial hemorrhages on MRI.References
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